Ingredients: ondansetron (Zofran), B-complex, magnesium CL, zinc, manganese, copper, selenium Revive and Thrive Cocktail | $250 Experience a Total Wellness Makeover with Our Myers Cocktail Infusion
MaxN-Fuze ($92) antioxidant and glutathione-supporting dietary supplement that guards against free radicals in the body
This cognitive relief can be transformative for people who have struggled with willpower-based approaches
GLP-1 receptor activation suppresses appetite, slows gastric emptying, enhances glucose-dependent insulin secretion, and helps restrain inappropriate glucagon activity

Target Consumer Segments Adults Concerned With Cellular Health (3060) : men and women seeking antioxidant-rich supplements for detoxification, oxidative stress reduction, and immune system support Beauty & Skin Health Enthusiasts (2545) : individuals prioritizing brighter skin tone, anti-aging effects, and protection from environmental pollutants Health-Conscious Urban Professionals (3050) : exposed to high oxidative stress and looking for daily detoxification and liver support through natural glutathione supplementation Individuals With Chronic Fatigue Or Weak Immunity (3565) : aiming to improve energy, enhance immunity, and support glutathione depletion from stress or illness Aging Adults Focused On Longevity (5070) : interested in preventative solutions to combat free radicals, inflammation, and cellular degeneration Nutraceutical Consumers Seeking Skin Brightening (2040) : particularly in markets where skin whitening is a popular cosmetic and wellness trend Regional Consumer Demand North America Market Insight : Strong demand from beauty, detox, and biohacking markets drives consistent growth

Source: Pocket Manual of Therapy (Bartoccioni et al.) / [FDA] / [The Lancet] / [NEJM] Learn more with the official bot on Telegram: #Medicine #TerapiaAI #SleepApnea #Tirzepatide #MetabolicHealth To view or add a comment, sign in ALERT NEWS: THERAPEUTIC EVOLUTION IN OBESITY AND SLEEP APNEA Obesity management is undergoing a clinical metamorphosis: no longer just a challenge to the scale, but a targeted intervention on systemic complications